Bionano Genomics, Inc. Debt Conversion, Converted Instrument, Amount
Bionano Genomics, Inc. (BNGO) reported Debt Conversion, Converted Instrument, Amount of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-08-10
- Bionano Genomics, Inc. debt conversion, converted instrument, amount for the quarter ending 2026-06-30 was $0.00.
- Bionano Genomics, Inc. debt conversion, converted instrument, amount for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Bionano Genomics, Inc. debt conversion, converted instrument, amount for the quarter ending 2025-12-31 was $0.00.
- Bionano Genomics, Inc. debt conversion, converted instrument, amount for the quarter ending 2025-09-30 was $0.00.
- Bionano Genomics, Inc. debt conversion, converted instrument, amount for fiscal 2025 was $350.00K.
- Bionano Genomics, Inc. debt conversion, converted instrument, amount for fiscal 2024 was $0.00.
- Bionano Genomics, Inc. debt conversion, converted instrument, amount for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Bionano Genomics, Inc. debt conversion, converted instrument, amount for fiscal 2018 was $14.90M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $350.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $350.00K 10-Q · filed 2025-11-13 | $350.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $350.00K 10-Q · filed 2026-08-10 | $350.00K derived: sum of 3 quarters · filed 2026-08-10 | $350.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $350.00K 10-Q · filed 2026-05-13 | $350.00K derived: sum of 2 quarters · filed 2026-05-13 | $350.00K derived: sum of 3 quarters · filed 2026-05-13 | $350.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $0.00 10-K · filed 2026-03-23 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | |||
| 2018-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $14.90M 10-K · filed 2020-03-10 | ||
| 2018-09-30 | $14.90M 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |